Hereditary angioedema (HAE) is primarily treated by allergists and immunologists, who serve as the main specialists for long-term diagnosis and management. Because HAE is a rare condition affecting roughly 1 in 50,000 people, most primary care doctors see very few cases, and patients typically need specialist-led care to get an accurate diagnosis and an effective treatment plan.
Allergists and Immunologists Lead HAE Care
Allergists and immunologists are the doctors most closely associated with HAE management. They understand the underlying immune system dysfunction, order the right diagnostic blood work, and prescribe the specialized medications that prevent or treat attacks. For rarer subtypes of HAE where the standard protein levels come back normal, a referral to a dedicated HAE specialist (often an allergist or sometimes a hematologist) can help guide genetic testing and confirm the diagnosis.
Other specialists frequently involved include pulmonologists, who may be consulted when swelling affects the airways, and internists who coordinate broader health concerns. Once a treatment plan is stable, your primary care provider or nurse practitioner can handle routine follow-up, but the specialist remains the anchor of your care team.
How HAE Is Diagnosed
Diagnosis hinges on a set of blood tests that measure a protein called C1 inhibitor. In Type I HAE (the most common form), levels of this protein in the blood are low. In Type II HAE, the protein is present in normal amounts but doesn’t function properly. Doctors check both the quantity and the functional activity of C1 inhibitor, along with a complement protein called C4, which is almost always low during and between attacks.
These blood tests require careful handling. Samples for functional testing must be separated and frozen to extremely cold temperatures within two hours of the blood draw. If they aren’t handled correctly, results can be inaccurate. This is one reason why getting tested at a center familiar with HAE matters: labs that rarely process these samples are more likely to produce misleading results.
The Multidisciplinary Team
HAE management works best when multiple professionals coordinate. Beyond allergists and immunologists, the broader care team can include emergency physicians, specialty pharmacists, nurses, and mental health providers. Specialty pharmacists play a growing role, handling medication selection, teaching patients how to self-administer injectable treatments, and conducting follow-up by phone or telemedicine to track how well a therapy is working.
This kind of coordination is especially valuable for rare diseases. Centers with more HAE patients tend to develop standardized protocols that improve outcomes, reduce unnecessary emergency visits, and ensure every member of the care team shares the same information. When pharmacists participate in these multidisciplinary teams, studies show patients experience fewer hospital visits and better quality of life.
Emergency Physicians and Action Plans
Emergency doctors are often the first point of contact during a severe HAE attack, particularly one involving throat swelling. The American College of Emergency Physicians recognizes that ER staff play a critical role in quickly recognizing HAE symptoms, since the condition is frequently misdiagnosed as an allergic reaction or a side effect of blood pressure medication.
Your HAE specialist will typically provide you with an emergency action plan: a document you carry or keep accessible that lists your diagnosis, your prescribed on-demand treatment, and instructions for medical staff who may be unfamiliar with the condition. This plan can save critical time in an emergency room where staff may have never encountered HAE before.
Specialists for Children and Adolescents
Most people with HAE develop their first symptoms during childhood, with a median age of onset around 11 years. Attacks often become more frequent and severe during puberty. International guidelines recommend that children and adolescents with HAE be treated by medical professionals experienced in the condition or at specialized centers, rather than by general pediatricians alone.
Pediatric HAE care has some distinct features. Medication doses are adjusted regularly based on the child’s weight and age. Treatment decisions are made collaboratively with families, factoring in how the disease and therapy affect daily life, school attendance, and social participation. A swelling calendar or tracking app is recommended to document attacks, early warning signs, triggers, and which medications were used.
The emotional toll deserves attention too. Fear of attacks, pain, and visible swelling can cause significant psychological stress in young patients. Guidelines recommend a holistic approach that includes psychological support and counseling for both the child and the family, provided by professionals who understand the disease.
What Ongoing Management Looks Like
HAE care isn’t a one-time consultation. International guidelines from the World Allergy Organization and the European Academy of Allergy and Clinical Immunology recommend that every patient be evaluated for long-term preventive therapy based on how active their disease is, how much it burdens daily life, and their personal preferences. Patients on preventive treatment are monitored through scheduled monthly follow-ups, with additional visits as needed when breakthrough attacks occur.
At each visit, your specialist will review the nature of recent attacks, any early warning symptoms you noticed, possible triggers, and whether your current medication is controlling the disease well enough. The goal is to minimize or eliminate attacks entirely, not just to make them less severe.
Current Treatment Approaches
HAE treatment falls into two categories: on-demand therapy for active attacks and preventive (prophylactic) therapy to reduce attack frequency. Several injectable and oral options exist for prevention, and the treatment landscape continues to expand. The most recent FDA approval is donidalorsen, the first RNA-targeted preventive therapy for HAE, approved for patients 12 and older. It works by reducing the body’s production of a protein involved in the swelling pathway and is self-administered as a subcutaneous injection every four to eight weeks.
Your specialist will help you choose among available therapies based on your attack frequency, the severity of your episodes, your comfort with injections versus oral medication, and how each option fits into your routine. Many patients learn to self-administer their treatments at home, which reduces dependence on emergency rooms and gives a greater sense of control over the condition.
Finding the Right Specialist
If you suspect HAE or have a family history of the condition, starting with your primary care doctor for an initial referral to an allergist or immunologist is the most direct path. Patient advocacy organizations, such as the US Hereditary Angioedema Association, maintain directories of physicians with HAE expertise. Because this is a rare disease, not every allergist will have deep experience with it, so seeking out a provider who specifically lists HAE among their focus areas can make a meaningful difference in the quality of your care.